Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-03-06
2011-10-04
Shiao, Rei-tsang (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S566000
Reexamination Certificate
active
08030344
ABSTRACT:
The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions. One aspect of the invention provides compounds of formula (1):in which T, A and X are as described herein.
REFERENCES:
patent: 2754286 (1956-07-01), Martin
patent: 3208990 (1965-09-01), Benz et al.
patent: 3263924 (1966-08-01), Kolze
patent: 4994479 (1991-02-01), Mase et al.
patent: 5332750 (1994-07-01), Mederski et al.
patent: 5366878 (1994-11-01), Pederson
patent: 5635377 (1997-06-01), Pederson
patent: 5652355 (1997-07-01), Metelev et al.
patent: 6034251 (2000-03-01), Aslanian et al.
patent: 6174905 (2001-01-01), Suzuki et al.
patent: 6180844 (2001-01-01), Fujita et al.
patent: 6541661 (2003-04-01), Delorme et al.
patent: 6653309 (2003-11-01), Saunders et al.
patent: 7253204 (2007-08-01), Delorme et al.
patent: 7595343 (2009-09-01), Delorme et al.
patent: 2004/0087798 (2004-05-01), Yamada
patent: 2004/0147569 (2004-07-01), Suzuki et al.
patent: 2004/0186148 (2004-09-01), Shankar et al.
patent: 2005/0096222 (2005-05-01), Hidaka et al.
patent: 2005/0222410 (2005-10-01), Stokes et al.
patent: 2005/0288282 (2005-12-01), Delorme et al.
patent: 2006/0058298 (2006-03-01), Delorme et al.
patent: 2006/0063210 (2006-03-01), Li et al.
patent: 2007/0173527 (2007-07-01), Bressi et al.
patent: 2007/0213330 (2007-09-01), Delorme et al.
patent: 2008/0132503 (2008-06-01), Moradei et al.
patent: 2480356 (2003-10-01), None
patent: 2484065 (2003-11-01), None
patent: 2615105 (2007-01-01), None
patent: 0847992 (1998-06-01), None
patent: 96/258863 (1996-09-01), None
patent: 11-269146 (1999-10-01), None
patent: 11-302173 (1999-11-01), None
patent: 2000-256194 (2000-09-01), None
patent: 2001131130 (2001-05-01), None
patent: 2002-332267 (2002-11-01), None
patent: 00/71703 (2000-11-01), None
patent: WO 01/38322 (2001-05-01), None
patent: 01/70675 (2001-09-01), None
patent: WO 02/069947 (2002-09-01), None
patent: WO 03/024448 (2003-03-01), None
patent: WO 03/075929 (2003-09-01), None
patent: WO 03/076395 (2003-09-01), None
patent: WO 03/076400 (2003-09-01), None
patent: WO 03/076401 (2003-09-01), None
patent: WO 03/076421 (2003-09-01), None
patent: WO 03/076422 (2003-09-01), None
patent: WO 03/076438 (2003-09-01), None
patent: 03/087057 (2003-10-01), None
patent: WO 03/092686 (2003-11-01), None
patent: 2004005513 (2004-01-01), None
patent: 2004/035525 (2004-04-01), None
patent: 2004/069823 (2004-08-01), None
patent: WO 2005/030705 (2005-04-01), None
patent: 2005/092899 (2005-10-01), None
patent: WO 2006/122319 (2006-11-01), None
patent: 2007/118137 (2007-10-01), None
Zhou et al., (2001) “Cloning and Characterization of a Histone Deacetylaes, HDAC9”, Proc. Natl. Acad. Sci. U.S.A., 98:10572-10577.
Pon, R.T. (1993) “Solid-Phase Supports for Oligonucleotide Synthesis” Methods in Molec. Biol. 20: 465-496.
Csordas, “On the biological Role of histone Acetylation”, Biochem. J., 265: 23-38 (1990).
Taunton et al., “A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p”, Science, 272:408-411 (1996).
Grozinger et al., “Three Proteins Define a Class of Human Histone Deacetylases Related to Yeast Hda1p”, Proc. Natl. Acad. Sci. USA, 96:4868-4873 (1999).
Kao et al., (2000) “Isolation of a Novel Histone Deacetylase Reveals that Class I and Class II Deacetylases Promote SMRT-Mediated Repression”, Gene & Development 14:55-66.
Hu, et al. (2000) “Cloning and Characterization of a Novel Human class I Histone Deacetylase that Functions as a Transcription Factor” J. Bio. Chem. 275:15254-15264.
Kao et al., (2002) “Isolation and Characterization of Mammalian HDAC10, a Novel Histone Deacetylase”, J. Biol. Chem., 277:187-193.
Gao et al, (2002) “Cloning and Functional Characterization of HDAC11, a Novel Member of the Human Histone Deacetylase Family” J. Biol. Chem. 277(28): 25748-25755.
Shore, (2000) “The Sir2 Protein Family: A Novel Deacetylase for Gene Silencing and More” Proc. Natl. Acad. Sci. U.S.A., 97:14030-14032.
Cress et al., (2000) “Histone Deacetylases, Transcriptional Control, and Cancer” J. Cell. Phys., 184:1-16.
Ng et al., (2000) “Histone Deacetylases: Silencers for Hire” TIBS, 25(March):121-126.
Magnaghi Jaulin et al., (2000) “Histone Acetylation and the Control of the Cell Cycle” Prog. Cell Cycle Res., 4:41-47.
Richon et al., (1998) “A Class of Hybrid Polar Inducers of Transformed Cell Differentiation Inhibits Histone Deacetylases” Proc. Natl. Acad. Sci. USA, 95:3003-3007.
Yoshida et al., (1990) “Potent and Specific Inhibition of Mammalian Histone Deacetylase Both in Vivo and in Vitro by Trichostatin A” J. Biol. Chem., 265:17174-17179.
Yoshida et al., (1988) “Reversible Arrest of Proliferation of Rat 3Y1 Fibroblasts in Both the G1 adn G2 Phases by Trichostatin A” Exp. Cell Res., 177:122-131.
Finnin et al., (1999) “Structures of a Histone Deacetylase Homolgue Bound to the TSA and SAHA Inhibitors” Nature, 401:188 193.
Kijima et al., (1993) “Trapoxin, an Antitumor Cyclic Tetrapeptide, is an Irreversible Inhibitor of Mammalian Histone Deacetylase” J. Biol. Chem., 268(30):22429-22435.
Kwon et al., (1998) “Depudecin induces Morphological Reversion of Transformed Fibroblasts via the Inhibition of Histone Deacetylase” Proc. Natl. Acad. Sci. USA 95(7):3356-3361.
Ramchandani et al. (1997) “Inhibition of Tumorigenesis by a Cytosine-DNA, Methyltransferase, Antisense Oligodeoxynucleotide” Proc. Natl. Acad. Sci. USA 94:684-689.
Seto, et al. (1993) “Molecular Self-Assembly Through Hydrogen Bonding: Aggregation of Five Molecules to Form a Discrete Supramolecular Structure”, J. Amer. Chem. Soc., 115: 1321-1329.
Harris et al. (1999) “Sequential N-Arylation of Primary Amines as a Route to Alkyldiarylamines” J.Org.Chem., 64: 6019-6022.
Perry et al., Abstract (1992) J Org Chem., 57:2883-2887.
Miletin et al., Abstract (2001) Molecules, 6:603-613.
Beer et al., Abstract (1996) J. Chem Soc., Dalton Trans., vol. 11, pp. 2341-2346.
Frechette Sylvie
Isakovic Lubo
Moradei Oscar
Paquin Isabelle
Roy Simon
McDonnell Boehnen & Hulbert & Berghoff LLP
MethylGene Inc.
Shiao Rei-tsang
LandOfFree
Inhibitors of histone deacetylase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of histone deacetylase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of histone deacetylase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4280324